ANTCF
Price:
$0.0038
Market Cap:
$4.84M
Aion Therapeutic Inc. offer medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-04-21
Stock Exchange
PNK
Ticker
ANTCF
According to Aion Therapeutic Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.38. This represents a change of -87.13% compared to the average of -2.95 of the last 4 quarters.
The mean historical PE Ratio of Aion Therapeutic Inc. over the last ten years is -11.23. The current -0.38 PE Ratio has changed 238.45% with respect to the historical average. Over the past ten years (40 quarters), ANTCF's PE Ratio was at its highest in in the October 2019 quarter at 1.29. The PE Ratio was at its lowest in in the July 2015 quarter at -175.12.
Average
-11.23
Median
-1.58
Minimum
-71.76
Maximum
-0.73
Discovering the peaks and valleys of Aion Therapeutic Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 975.37%
Maximum Annual PE Ratio = -0.73
Minimum Annual Increase = -98.67%
Minimum Annual PE Ratio = -71.76
Year | PE Ratio | Change |
---|---|---|
2024 | -0.84 | -85.22% |
2023 | -5.70 | 678.46% |
2022 | -0.73 | -28.34% |
2021 | -1.02 | -52.08% |
2020 | -2.13 | 123.51% |
2019 | -0.95 | -98.67% |
2018 | -71.76 | 975.37% |
The current PE Ratio of Aion Therapeutic Inc. (ANTCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.43
5-year avg
-2.09
10-year avg
-11.23
Aion Therapeutic Inc.’s PE Ratio is less than Amexdrug Corporation (4.30), less than Aspen Pharmacare Holdings Limited (9.41), greater than Antisense Therapeutics Limited (-3.23), greater than Alterola Biotech, Inc. (-2.85), greater than HLS Therapeutics Inc. (-3.60), less than Cipher Pharmaceuticals Inc. (16.01), less than Cannara Biotech Inc. (10.07), greater than Knight Therapeutics Inc. (-17.21), greater than The BC Bud Corporation (-5.76), greater than AusCann Group Holdings Ltd (-2.17),
Company | PE Ratio | Market cap |
---|---|---|
4.30 | $338.82K | |
9.41 | $5.44B | |
-3.23 | $19.64M | |
-2.85 | $4.38M | |
-3.60 | $79.80M | |
16.01 | $258.20M | |
10.07 | $46.44M | |
-17.21 | $362.06M | |
-5.76 | $4.81M | |
-2.17 | $1.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aion Therapeutic Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aion Therapeutic Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aion Therapeutic Inc.'s PE Ratio?
How is the PE Ratio calculated for Aion Therapeutic Inc. (ANTCF)?
What is the highest PE Ratio for Aion Therapeutic Inc. (ANTCF)?
What is the 3-year average PE Ratio for Aion Therapeutic Inc. (ANTCF)?
What is the 5-year average PE Ratio for Aion Therapeutic Inc. (ANTCF)?
How does the current PE Ratio for Aion Therapeutic Inc. (ANTCF) compare to its historical average?